Immutep
IMMP
21 hedge funds and large institutions have $8.31M invested in Immutep in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.02% less ownership
Funds ownership: 0.64% → 0.62% (-0.02%)
5% less funds holding
Funds holding: 22 → 21 (-1)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
26% less capital invested
Capital invested by funds: $11.2M → $8.31M (-$2.93M)
61% less call options, than puts
Call options by funds: $57K | Put options by funds: $147K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$71.5K |
| 2 |
IAN
Integrated Advisors Network
Dallas,
Texas
|
+$26.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21.5K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$21.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$17.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$205K |
| 2 |
State Street
Boston,
Massachusetts
|
-$112K |
| 3 |
Millennium Management
New York
|
-$97.5K |
| 4 |
Morgan Stanley
New York
|
-$76.3K |
| 5 |
SC
Saturna Capital
Bellingham,
Washington
|
-$42K |
IMMP Hedge Fund Activity: Q3 2022 in Review
21 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q3 2022, worth a combined $8.31M — down 26% from $11.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IMMP and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 5 added.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $71.5K. The largest seller was Trellus Management Company, exiting entirely with an estimated $205K sold.
- 21 institutional investors held Immutep (IMMP) as of Q3 2022, down from 22 in Q2 2022.
- Funds reported $8.31M of Immutep stock for Q3 2022, down 26% quarter-over-quarter.
- 3 funds opened new Immutep positions in Q3 2022 and 4 closed out, a net change of -1 holder.
- The largest Immutep buyer in Q3 2022 was Balyasny Asset Management, an estimated $71.5K added.
- The largest Immutep seller in Q3 2022 was Trellus Management Company, an estimated $205K sold.
Based on aggregated 13F filings for Q3 2022.